- Study protocol
- Open Access
Improving quality of life in cancer patients through higher participation and health literacy: study protocol for evaluating the oncological social care project (OSCAR)
BMC Health Services Research volume 19, Article number: 754 (2019)
Cancer patients experience psychological and social distress due to their medical treatment and social issues. However, continuous and specialized social support is still lacking. In Germany, a group of company health insurance funds has developed an approach to support cancer patients with monthly structured interviews conducted by specially trained Social Care Nurses. The nurses will identify patient needs in order to provide help with medical, personal, and social matters. One aim of the scientific evaluation is to analyze the effect of the consultations on various patient-reported outcomes, especially quality of life. The evaluation concept will be described in this study protocol.
The evaluation is a non-randomized, controlled, multi-center intervention study with a mixed-method design. It consists of three research modules which include primary data from questionnaires, and claims data from the health insurance funds. In Module 1, cancer patients will be recruited to form an intervention group (OSCAR, n = 150) and a control group (n = 200) in four study centers for a period of 1 year. One baseline and three follow-up questionnaires will be conducted to survey the patient-reported outcomes. Relevant secondary outcomes are health literacy, participation, and physician-patient communication. In Module 2, claims data will be used to analyze cost effects and thereby assess effectivity and hospitalization. Module 3 will involve a qualitative analysis of project diaries kept by the Social Care Nurses. The diaries will record the nurses’ practical experiences and the benefits of deploying OSCAR across the German healthcare system.
OSCAR is an innovative way of providing cancer patients with continuous support to improve their quality of life. The evaluation concept aims to assess the effects of the monthly consultations by the Social Care Nurses on the patients, and will use a mixed-method design. The results are important for assessing the transferability of OSCAR to the healthcare system as a whole.
German Clinical Trials Register (DRKS-ID: DRKS00013640). Registered 29 December 2017.
Demand for social support for cancer patients
Cancer cause a high number of incident cases in Germany every year (229,920 women and 252,550 men in 2013) . Due to the progression of the diseases, patients and their relatives experience distress caused by medical treatment and social issues [2, 3]. The misunderstanding of the disease can lead to inappropriate self-assessments of one’s prognosis and a choice of unsuitable medical treatments . Simultaneously, patients receive overtreatment even though they have an incurable disease . In these situations, palliative care could be appropriate for improving quality of live . Enhancing palliative care can help patients to find suitable medical treatments that can increase quality of life. However, the specific needs of cancer patients are not taken into adequate account by the healthcare system because of a lack of palliative care . Currently, patient navigation programs are used to help patients with medical, nursing, psychological, and healthcare-related issues. Recent studies have attempted to evaluate the impact of these programs (such as Onkolotse by the Saxon Cancer Society) [8, 9]. In this context, patient-reported outcomes (PROs) are very important for examining the subjective benefit of interventions from the patient’s perspective, with the focus on relevant outcomes (e.g. quality of life) .
Development of the OSCAR project
The Oncological Social Care Project (OSCAR) was developed by the German company health insurance fund Pronova BKK. The concept is based on the Saxon Cancer Society’s Onkolotse navigation program for cancer patients. An essential component of OSCAR is the additional social support provided by the Social Care Nurses (SCNs), who aim to identify deficits in healthcare utilization by cancer patients and support them in relevant areas (e.g. the medical treatment of the cancer, psychosocial support for anxiety, practical tips regarding social security services, and organization of rehabilitation). Moreover, the SCNs are regular and accessible contact partners in a complex and fragmented multidisciplinary treatment process. Each patient is accompanied for 1 year, regardless of whether they are being treated as inpatients or outpatients, or are currently not receiving any therapy. The intervention aims to access and improve the quality of life for patients with advanced cancer and a poor prognosis. It uses twelve structured interviews over the course of 1 year. The SCNs received training from the Saxon Cancer Society. OSCAR is implemented by five SCNs at four locations.
The OSCAR evaluation is a mixed-method study consisting of three research modules. Modules 1 and 2 involve a non-randomized, controlled, multi-center intervention study which compares primary data from regularly conducted questionnaires and claims data from German statutory health insurance funds in the intervention and control groups. In addition, a qualitative content analysis is planned in module 3 and will be based on the project diaries completed by each SCN. The analysis will assess OSCAR’s effectivity and the benefit of implementing it in the German healthcare system (Fig. 1).
To compare quality of life over study period between the intervention group (patients who had met an SCN) and the control group (Module 1).
To compare the health literacy, participation, and physician-patient communication in the intervention and control groups (Module 1)
To explore the associations between quality of life and health literacy, participation, and physician-patient communication (Module 1)
To compare the incidence rate of outpatient visits in both groups (Modules 1 and 2)
To compare the healthcare costs in both groups (Module 2)
To assess the SCN’s practical experiences (Module 3)
Inclusion and exclusion criteria for participation in the evaluation survey in modules 1 and 2
Aged ≥18 years
At least a combination of one type of cancer and one operation and procedure, as defined by the ICD and OPS codes listed in Additional file 1
Module 1: primary data, patient-reported outcomes
The recruitment was carried out in four different hospitals with oncology departments across three cities in two states in Germany. Two of the hospitals are located in Berlin, while the other two are in Leverkusen and Duisburg.
In all four study sites, the SCNs recruited BKK-insured patients for the intervention group by obtaining informed consent. The SCNs are responsible for the monthly consultations to support the patients in the intervention group. Patients who are insured with a different provider were recruited by Study Nurses (SNs) for the control group. The SNs’ main task is to conduct the evaluation questionnaires in both study groups up to four times within 1 year. The evaluation’s baseline survey will be conducted after recruitment (t0) and followed up after 90 (t1), 180 (t2), and 365 (t3) days. The patients can choose between personal, telephone, and postal interviews, depending on their health status and which method is most comfortable for them. Dividing responsibilities between SCNs and SNs is necessary to ensure the independence of the evaluation surveys. Patients in both groups were recruited at the same study sites between February 2018 and the end of February 2019.
The items for the evaluation questionnaire are listed in Table 1:
Further instruments are used to measure sociodemographic variables, especially with regard to age, sex, migration status, and social status [19,20,21]. Finally, participants in the intervention group will be asked to evaluate their contact with the SCN for the last 3 months. The items are related to specific consultation topics and whether or not the support was useful for the respective topic. Participants will also be asked about the quality and quantity of contact with the SCN.
Sample size calculation
A sample size of 100 participants in the intervention group and 150 in the control group will reach a power of 80% at a two-sided level of significance of 5% to detect a difference in the EORTC QLQ-C30 (scores range from 0 to 100) with a Cohen’s d effect size of 0.4 (mean difference of ten scores and standard deviation (SD) of 25 scores) . Given that the effect size might be smaller due to a lower mean difference or higher SD, and that the severity of cancer can cause higher dropout rates, we aim to include 150 participants in the intervention group and 200 in the control group (so a total sample size of 350 participants).
The sample size calculation based on the t-test was used in spite of the intended analysis with a baseline-adjusted repeated-measures linear mixed model (ANCOVA, three-level random intercept model to account for repeated measures in patients and clustering in centers). It can be shown  that a conservative approach for estimating sample sizes has the same power as a t-test with n subjects where p is the variance deflation factor, calculated by the correlation of baseline and follow-up measures. Assuming the worst case of p = 0 leads to the sample size based on the t-test.
Statistical analysis plan
All statistical tests are performed using Stata IC15 (StataCorp, 2017, College Station, TX, USA). The primary hypothesis will be tested at a two-sided significance level of α = 0.05. All secondary hypotheses will be tested within an exploratory framework.
Descriptive statistics and the number of participants reflected in the calculation (n) will be presented in each group. For continuous variables, mean with SD for normal distribution and median with interquartile range (IQR) for other distribution variables will be presented. For categorical data, frequencies and percentages will be displayed for each category. Graphic methods such as box plots and line graphs will be used for visualizing the data.
The comparison of EORTC QLQ-C30 (global health status as a primary outcome), physician-patient communication (scores), health competence (scores), participation (scores), and knowledge (scores) over the study period between the groups will be reported as mean and 95% CI, and performed using a linear mixed model (LMM) with three levels over all available time points. Random intercepts for the patient ID and for the study clinics are included in the model to account for the cluster structure of the data. To keep selection bias to a minimum, we will develop a propensity score for adjusting baseline factors. The propensity score will be used with the inverse probability of treatment weighting (IPTW) method because the results from this method are similar to a randomized trial [23, 24].
The number of outpatient visits will be counted and the study time will be calculated over the follow-up time for each patient. The incidence rate of outpatient visits per person-time will be presented, and Poisson regression will be used to compare the incidence rate between groups.
All outcomes will be analyzed using modified intent-to-treat populations including all subjects who receive at least one consultation from an SCN and for whom at least the first follow-up assessment at Visit 1 (at 3 months) is available.
Dropouts and missing data
Reasons for dropouts will be documented and reported. If patients are alive and missings are assumed to be missing at random (MAR), we will use multiple imputation methods based on ten imputed data sets  with multiple imputation by chained equations (MICE).
Module 2: secondary data, claims data from health insurance funds
Design and participants
Another part of the OSCAR evaluation involves analyzing claims data from the BKK health insurance funds. In contrast to the patient-reported parameters in Module 1, the claims data will make it possible to analyze objective parameters. This kind of data is a valid and relevant source, and has been used in many healthcare research projects in Germany. The data from Modules 1 and 2 will not be linked. If available, the secondary data will be analyzed for the period up to 12 months before and after enrollment.
Inclusion and exclusion criteria
This data is only available for the patients in the intervention group, who have health insurance with BKK (n = 150). A new, independent and anonymous control group will therefore be drawn from BKK-insured patients who did not take part in the OSCAR intervention (n = 600). All included patients must meet the inclusion and exclusion criteria mentioned above. Furthermore, the patients in the control group should be treated in hospitals comparable to those where the patients in the intervention group were treated. In addition, the control group will be matched with the intervention group by age, gender, and diagnosis.
The following aspects are of interest: time-to-death, all costs of treatment, and the incidence rate of hospitalization and outpatient visits.
Statistical analysis plan
Paired t-test or Wilcoxon signed rank test will be performed to compare the costs of treatment per month. The generalized estimating equation (GEE) for Poisson regression will be applied to compare the incidence rate of hospitalization and outpatient visits between intervention and matched controls. Kaplan-Meier curve and Cox regression analysis will be performed to compare time-to-death between the groups.
Module 3: qualitative analyses of SCN project diaries
Design and participants
The qualitative analyses of project diaries provide important insights into the work of the SCNs. The nurses will be asked to record their feedback concerning positive aspects of the OSCAR program, as well as opportunities for further improvements with regard to the transferability of OSCAR to the regular healthcare system. For each patient, the SCNs will record the number of additional consultations between two planned monthly consultations, and any recommendations to visit partners in their supply network.
The following aspects are of interest for the qualitative content analysis: acceptance of OSCAR among the patients and among the participating hospitals; number of additional consultations for patients; subjective feedback and reasons for early program termination by the patient; barriers to consultations.
This study aims to evaluate whether the OSCAR program can improve quality of life for patients with advanced cancers and a poor prognosis by enhancing health literacy and participation in therapy planning through continued supportive care from an SCN. A variety of approaches currently exist for developing and evaluating navigation programs for cancer patients. One example is the Onkolotse project from the Saxon Cancer Society. It involves certified nurses, psychologists, and social workers, who having contact with cancer patients about 20 times within 1 year. The evaluation of this project focuses on the number of hospital admissions and psychological stress . Nurses from the non-profit association Group Health contact patients weekly via telephone, and meet with them face-to-face at least once . The nurses aim to develop strategies that address distress and focus on quality of life. In another project, experienced nurses attempt to identify patient needs with three different assessment tools and personal conversations . The endpoints in this study are e.g. patient satisfaction, acceptance of the nurses’ advice, and the use of support services for cancer.
Nevertheless, there is a lack of implementation of these approaches in Germany. OSCAR was developed to provide patients with a year of regular support in matters regarding their cancer. This is a useful addition to existing structures such as the social services provided by hospitals, which address the immediate needs of patients after hospital discharge. Improving the continuity of care and building patient competences are important for cancer patients in a fragmented healthcare system. Moreover, suitable healthcare structures and contract frameworks are necessary for delivering low-threshold access to palliative care and supporting consultations.
Experiences gathered with OSCAR could be transferred to other chronic somatic diseases which are associated with severe physical and psychological distress in patients and their relatives.
One advantage of the evaluation is the mixed-method design, which includes patient-reported outcomes, claims data from health insurance funds, and qualitative analyses of the SCNs’ project diaries. To evaluate the effects of continuous SCN support in Module 1, a prospective, non-randomized, multicenter, longitudinal study design was applied. Our patients were not assigned randomly, due to the limitation of the SCNs, who were trained and supported by the BKK insurance fund. Since randomization was not carried out, we are concerned about selection bias. Therefore, the baseline characteristics will be compared and we will control for baseline imbalance by using propensity score in our analysis. The propensity score with the inverse probability of treatment weighting (IPTW) method will be applied because the results from this method are similar to a randomized trial [23, 24]. For Module 2, we will match the intervention and control cases in order to reduce bias and confounding factors as much as possible. Moreover, given the severity of the patients’ conditions, we aimed to reduce the interview time by using the short versions of the instruments, if available, rather than applying generic instruments. In conclusion, we believe our study provides healthcare support for cancer patients. Hopefully, it can be applied for other severe chronic diseases. The evaluation of OSCAR is currently ongoing. In terms of providing healthcare support according to the patient’s needs, we expect our study to show that SCN support has a positive effect on the patient’s quality of life, health literacy, and participation in therapy planning.
Availability of data and materials
German modified version of the Autonomy Preference Index
Decision Conflict Scale
German Clinical Trials Register
European Organisation for Research and Treatment of Cancer
Generalized estimating equation
European Health Literacy Survey
Illness Perception Questionnaire
Inverse probability of treatment weighting
Missing at random
Multiple imputation by chained equations
Oncological Social Care Project
Oslo Social Support Scale
Patient Reaction Assessment
Social Care Nurse
Bericht zum Krebsgeschehen in Deutschland 2016. Robert Koch Institut 2016. https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebsgeschehen/Krebsgeschehen_node.html. Accessed 02 July 2019.
Kunzler A, Zindel A, Znoj HJ, Bargetzi M. Distress among cancer patients and their partners in the first year after diagnosis. Praxis (Bern 1994). 2010;99(10):593–9.
Flatten G, Junger S, Gunkel S, Singh J, Petzold E. Traumatic and psychosocial distress in patients with acute tumors. Psychother Psychosom Med Psychol. 2003;53(3–4):191–201.
Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, et al. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012;367(17):1616–25.
Wedding U, Meran JG, Höffken K. Overtreatment in oncology: when does less become more? Onkologe. 2008;14(7):691–700.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.
Hui D, Bruera E. Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol. 2016;13(3):159-71.
Porzig R, Neugebauer S, Heckmann T, Adolf D, Kaskel P, Froster UG. Evaluation of a cancer patient navigation program ("Onkolotse") in terms of hospitalization rates, resource use and healthcare costs: rationale and design of a randomized, controlled study. BMC Health Serv Res. 2018;18(1):413.
Fiscella K, Whitley E, Hendren S, Raich P, Humiston S, Winters P, et al. Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomark Prev. 2012;21(10):1673–81.
Koller M, Neugebauer EAM. Methoden zur Messung von Patient-Reported Outcome (PRO). In: Pfaff H, Neugebauer EAM, Glaeske G, Schrappe M, editors. Lehrbuch Versorgungsforschung Systematik - Methodik - Anwendung. Stuttgart: Schattauer; 2017. p. 102–7.
Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group. EORTC QLQ-C30 scoring manual. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
Gaab J, Bunschoten SL, Sprott H, Ehlert U. Illness Perception Questionnaire (deutsche Version). In: Bengel J, Wirtz M, Zwingmann C, editors. Diagnostische Verfahren in der Rehabilitation. Göttingen: Hogrefe; 2008. p. 109-11.
Brenk-Franz K, Hunold G, Galassi JP, Tiesler F, Herrmann W, Freund T, et al. Quality of the Physician-Patient Relationship – Evaluation of the German Version of the Patient Reactions Assessment (PRA-D). Z Allg Med. 2016;92(3):103-108.
Härter M, Simon D, Kriston L. Die deutsche modifizierte Fassung des Autonomie-Präferenz-Index (API-Dm). Klin Diagn Eval. 2011;4(1E):5–14. 1E.
O'Connor AM. User Manual - Decisional Conflict Scale. Ottawa: Ottawa Hospital Research Institute. © 1993 [Updated 2010]. https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf. Accessed 02 July 2019.
Lorini C, Santomauro F, Grazzini M, Mantwill S, Vettori V, Lastrucci V, et al. Health literacy in Italy: a cross-sectional study protocol to assess the health literacy level in a population-based sample, and to validate health literacy measures in the Italian language. BMJ Open. 2017;7(11):e017812.
Rattay P, Butschalowsky H, Rommel A, Prütz F, Jordan S, Nowossadeck E, et al. Utilization of outpatient and inpatient health services in Germany. Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2013;56(5):832–44.
Kocalevent R-D, Berg L, Beutel ME, Hinz A, Zenger M, Härter M, et al. Social support in the general population: standardization of the Oslo social support scale (OSSS-3). BMC Psychology. 2018;6(1):31.
Schenk L, Bau A-M, Borde T, Butler J, Lampert T, Neuhauser H, et al. A basic set of indicators for mapping migrant status. Recommendations for epidemiological practice. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2006;49(9):853–60.
Hoebel J, Müters S, Kuntz B, Lange C, Lampert T. Measuring subjective social status in health research with a German version of the MacArthur Scale. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2015;58(7):749–57.
Demographische Standards. Wiesbaden: Statistisches Bundesamt; 2004. https://www.destatis.de/DE/Methoden/Demografische-Regionale-Standards/textbaustein-demografische-standards.html. Accessed 02 July 2019.
Borm GF, Fransen J, Lemmens WA. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60(12):1234–8.
Deb S, Austin PC, Tu JV, Ko DT, Mazer CD, Kiss A, et al. A review of propensity-score methods and their use in cardiovascular research. Can J Cardiol. 2016;32(2):259–65.
Kuss O, Blettner M, Borgermann J. Propensity score: an alternative method of analyzing treatment effects. Dtsch Arztebl Int. 2016;113(35–36):597–603.
Bodner TE. What improves with increased missing data imputations? Struct Equ Model Multidiscip J. 2008;15(4):651–75.
Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, et al. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014;32(1):12–8.
Berezowska A, Passchier E, Bleiker E. Evaluating a professional patient navigation intervention in a supportive care setting. Support Care Cancer. 2019;27:3281–3290.
We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité - Universitätsmedizin Berlin.
This research project received a grant from the Innovation Fund of the Federal Joint Committee (G-BA). Reference number: 01NVF17016. The G-BA had no role in the design of the study and collection, analysis and interpretation of data and in writing the manuscript.
Ethics approval and consent to participate
This project was approved by the ethics committees at Charité – Universitätsmedizin Berlin (EA2/192/17) and the Medical Association of North Rhine (2017429). The patients were enrolled in the study after providing written informed consent.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Frick, J., Schindel, D., Gebert, P. et al. Improving quality of life in cancer patients through higher participation and health literacy: study protocol for evaluating the oncological social care project (OSCAR). BMC Health Serv Res 19, 754 (2019). https://doi.org/10.1186/s12913-019-4585-0
- Social support
- Quality of life
- Patient preferences
- Health literacy